Drug profile · INN
pemoline
CYLERT
pemoline (CYLERT) is a unknown. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
FDA: approved
US status approved
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — pemoline
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 1
- Data quality
- 0.89
Quick answer
pemoline (CYLERT) is a unknown. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN pemoline
Brand CYLERT
Mechanism Unknown
Route ORAL
Formulation TABLET, CHEWABLE
Originator Teva Pharma GmbH
Mechanism of action
Unknown
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Frequently asked questions
What is pemoline?
pemoline (CYLERT) is a unknown. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for pemoline?
CYLERT is a marketed brand name for pemoline. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of pemoline?
pemoline has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.